Compare AdaptHealth Corp (AHCO) vs Five9 Inc (FIVN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AdaptHealth Corp vs Five9 Inc — how do they compare? AdaptHealth Corp trades at $5.75 (market cap $771.10M), while Five9 Inc trades at $34.25 (market cap $2.33B). The key difference: Five9 Inc is far larger — about 3× AdaptHealth Corp's market cap, and Five9 Inc is trading nearer its 52-week high, AdaptHealth Corp nearer its low. Which is the better fit depends on your goals.
| AHCO | FIVN | |
|---|---|---|
Market Cap | $771.10M | $2.33B |
Sector | Health | Technology |
52-Week High | $13.38 | $34.48 |
52-Week Low | $5.22 | $13.61 |
Enterprise Value | $2.79B | $2.48B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AdaptHealth (AHCO) trades at $5.77, up 2.12% today, but faces a bearish technical trend with recent earnings misses and a net loss of $70.79 million in 2025. Revenue grew to $3.24 billion, yet profitability remains challenged with a negative net margin. The company is refocusing on sleep and respiratory care after selling its diabetes unit, but faces multiple securities fraud investigations following a significant Q2 2026 earnings shortfall.
The outlook is cautious; while analyst consensus is bullish with a $11.00 price target, near-term risks from legal probes, execution missteps, and margin pressure outweigh potential upside. Investor sentiment is negative due to guidance cuts and operational challenges, making the stock high-risk despite its low valuation multiples.
FIVN trades at $33.80, up 3.59% today, near its 52-week high of $34.58. The stock shows a bullish technical trend with strong moving averages and has beaten earnings estimates for three consecutive quarters. Revenue growth is accelerating, with 2025 revenue reaching $1.15 billion and net income turning positive at $39.42 million, marking a significant improvement from prior losses. Recent management appointments and AI-driven subscription growth are positive catalysts.
The outlook is positive given earnings momentum and analyst support, but risks include high valuation multiples, ongoing legal scrutiny, and dependence on competitive AI adoption. With 61% of analysts rating it a Buy and a consensus target of $32.67, near-term upside appears limited, but execution on guidance could drive further gains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AdaptHealth Corp
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →About Five9 Inc
Five9 provides cloud-native contact center software that enables digital customer service, sales, and marketing engagement. The company's Virtual Contact Center platform combines core telephony functionality, omnichannel engagement capabilities, and various software modules into a unified cloud contact-center-as-a-service, or CCaaS, platform. Five9's artificial intelligence and automation portfolio supplements and enhances the firm's core CCaaS offerings, including solutions for digital self-service, agent assist technology, and workflow automation. Five9 also offers workforce optimization products that optimize call center efficiency through workforce management solutions, manage interaction quality, and track agent performance.
Read more on FIVN →
